EMAIL THIS PAGE TO A FRIEND

Journal of molecular and cellular cardiology

Transgenic overexpression of mitofilin attenuates diabetes mellitus-associated cardiac and mitochondria dysfunction.


PMID 25463274

Abstract

Mitofilin, also known as heart muscle protein, is an inner mitochondrial membrane structural protein that plays a central role in maintaining cristae morphology and structure. It is a critical component of the mitochondrial contact site and cristae organizing system (MICOS) complex which is important for mitochondrial architecture and cristae morphology. Our laboratory has previously reported alterations in mitochondrial morphology and proteomic make-up during type 1 diabetes mellitus, with mitofilin being significantly down-regulated in interfibrillar mitochondria (IFM). The goal of this study was to investigate whether overexpression of mitofilin can limit mitochondrial disruption associated with the diabetic heart through restoration of mitochondrial morphology and function. A transgenic mouse line overexpressing mitofilin was generated and mice injected intraperitoneally with streptozotocin using a multi low-dose approach. Five weeks following diabetes mellitus onset, cardiac contractile function was assessed. Restoration of ejection fraction and fractional shortening was observed in mitofilin diabetic mice as compared to wild-type controls (P<0.05 for both). Decrements observed in electron transport chain (ETC) complex I, III, IV and V activities, state 3 respiration, lipid peroxidation as well as mitochondria membrane potential in type 1 diabetic IFM were restored in mitofilin diabetic mice (P<0.05 for all). Qualitative analyses of electron micrographs revealed restoration of mitochondrial cristae structure in mitofilin diabetic mice as compared to wild-type controls. Furthermore, measurement of mitochondrial internal complexity using flow cytometry displayed significant reduction in internal complexity in diabetic IFM which was restored in mitofilin diabetic IFM (P<0.05). Taken together these results suggest that transgenic overexpression of mitofilin preserves mitochondrial structure, leading to restoration of mitochondrial function and attenuation of cardiac contractile dysfunction in the diabetic heart.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

82320
(±)-Propylene oxide, puriss. p.a., ≥99.5% (GC)
C3H6O
110205
(±)-Propylene oxide, ReagentPlus®, ≥99%
C3H6O
471968
(±)-Propylene oxide, ReagentPlus®, 99%
C3H6O
SAB2501731
Anti-CHCHD3 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2501548
Anti-CHCHD3 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1400591
Anti-CHCHD3 antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
SAB2106034
Anti-CHCHD3 antibody produced in rabbit, affinity isolated antibody
HPA042935
Anti-CHCHD3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106033
Anti-CHCHD3, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB2500268
Anti-COX4I1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1405644
Anti-COX4I1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2701802
Anti-cox4i1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA002485
Anti-COX4I1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2701230
Anti-IMMT antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA003184 Anti-MED12 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA003185
Anti-MED12 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV42419
Anti-MFN2 (AB1) antibody produced in rabbit, affinity isolated antibody
AV42420
Anti-MFN2 (AB2) antibody produced in rabbit, affinity isolated antibody, lyophilized powder
HPA030554
Anti-MFN2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
M6444
Anti-Mitofusin 2 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
M6319
Anti-Mitofusin-2 (N-Terminal) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1401273
Anti-OPA1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA036926
Anti-OPA1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA036927
Anti-OPA1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB5300321
Monoclonal Anti-COX4I1 antibody produced in mouse, clone 6B3, ascites fluid
SAB1402152
Monoclonal Anti-COX4I1 antibody produced in mouse, clone 4A10, purified immunoglobulin, buffered aqueous solution
SAB1403095
Monoclonal Anti-IMMT antibody produced in mouse, clone 1A8, purified immunoglobulin, buffered aqueous solution
WH0009927M3
Monoclonal Anti-MFN2 antibody produced in mouse, clone 4H8, purified immunoglobulin, buffered aqueous solution
SAB1404765
Monoclonal Anti-MFN2, (C-terminal) antibody produced in mouse, clone 6A8, purified immunoglobulin, buffered aqueous solution
M9073
Monoclonal Anti-Mitofusin 2 antibody produced in mouse, ~1.0 mg/mL, clone Mito-2, purified immunoglobulin, buffered aqueous solution